New evidence links respiratory diseases to rheumatoid arthritis
Much more research is needed, however, to establish causality, US researchers say.
Tag: Rheumatoid arthritis
One in four patients switch RA drugs in first year, study shows
Researchers have found that changing up therapies is common because of lack of efficacy.
Trial confirms excess cancer risk with tofacitinib
Safety trial was mandated after clinicians noted an increased incidence among patients.
Can DMARDs be stopped in patients with stable RA?
Trial findings suggest patients in remission might benefit from a more flexible approach to management of therapy, researchers say.
Tight control of RA ‘rapidly conquers fatigue’
An early treat-to-target strategy should improve fatigue as it seems to go hand-in-hand with disease activity, researchers say.
What’s a safe dose of glucocorticoids in RA?
Threshold dose for increased risk of cardiac events pinpointed, researchers say.
Second COVID-19 vax ‘needs to be timely’ in RA
Antibody titres are much lower in patients on DMARDs, researchers find.
Remission in rheumatoid arthritis: Can the csDMARD dose be halved?
Results of a randomised controlled trial are open to interpretation, expert says.
Medication review of RA picks up a worrying wheeze
A woman's breathlessness is picked up by her GP while discussing management options for her rheumatoid arthritis.
Most patients with RA ‘have never heard of treat-to-target’
But an Australian survey shows there's readiness to consider the approach.
